From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Abstract The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly gaining interest in neuroscience research. Much of this interest stems from recent